Developer docs
API playgroundTry for free, no card

Search company profiles

Encision

Full company profile

uuid0005pmc

Namestring
Encision
Legal namestring
Encision Inc.
Websiteurl
encision.com
Company typeenum
Public
Founded yearint
1991
Descriptiontext

Encision Inc. is a Boulder, Colorado-based medical device company founded in 1991 that develops and manufactures Active Electrode Monitoring (AEM®) technology and laparoscopic surgical instruments designed to eliminate stray energy burns to patients during minimally invasive surgery. The company's core technology — AEM® — electrically shields the laparoscopic instrument shaft and continuously monitors insulation integrity during use, automatically shutting down the electrosurgical generator when an insulation fault or capacitive coupling is detected. Its product portfolio includes the AEM EndoShield® 2 Burn Protection System (capital equipment, FDA 510(k) cleared June 2014), AEM enTouch® Reposable 2x Scissors, AEM e-Edge® disposable scissors, AEM Shield™ laparoscopic instruments, the EM3 Burn Protection Monitor (discontinued February 2026), and PowerGrip® bipolar instruments. The company also offers a distinctive 100% Hold Harmless Indemnity Guarantee to physicians and hospitals using AEM instrumentation.

Encision monetizes through three primary revenue streams: (1) one-time capital equipment sales of AEM monitors/burn protection systems to hospitals; (2) recurring disposable and reposable instrument sales (consumables such as electrodes, cables, scissors and sheaths); and (3) licensing/supply arrangements with surgical robotics companies including Intuitive Surgical (2009), Auris Health / J&J (2021), Human Xtensions (2023), and Vicarious Surgical (2023 PoC / 2024 MSA). Pricing is quote-based and not publicly disclosed; sales are handled via direct enterprise outreach out of Boulder, CO headquarters to US hospitals, supplemented by international channel partners Gytech PTY LTD (Australia) and Obex (New Zealand), and GPO contracts with Vizient (Second-Generation Innovative Technology Contract MS1306, covering ~97% of US academic medical centers and ~60% of acute care hospitals), Premier and HealthTrust. Encision was previously listed on AMEX (2004), moved to OTC Bulletin Board (2008), traded as ECIA on OTC US, and voluntarily deregistered from the SEC via Form 15 in January 2026 to pursue quotation on OTC Markets.

Recent financial performance shows a declining revenue trajectory attributed by management to Intuitive Surgical's robots displacing procedures that historically used AEM instrumentation: Q4 FY2026 net sales were $1,241K, down 12% sequentially from $1,413K in Q3 FY2026 and from $1,528K in Q2 FY2026. The company narrowed its Q4 FY2026 net loss to $96K (from $314K in Q3) and improved gross margin by 9.3 percentage points to 47.7% following a completed restructuring that reduced operating expenses by 22.6% and produced operating profitability in March. A $500,000 private placement completed August 19, 2025 is funding development of a new ENT (Ear, Nose and Throat) device planned for early 2026. CEO Gregory Trudel resigned in December 2025 after 12 years amid disagreement over company direction, and Robert Fries was appointed interim President and CEO.

Short descriptiontext

Encision Inc. is a Boulder, Colorado medical device company that develops AEM® Active Electrode Monitoring laparoscopic surgical instruments designed to eliminate stray energy burns, selling capital equipment and disposable/reposable instruments to US hospitals via GPO contracts and licensing to surgical robotics partners.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersBoulder, United States
HQ citystring
Boulder
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
electrosurgical safety devices, laparoscopic surgical instruments, active electrode monitoring, burn protection systems, minimally invasive surgery
Industry2 codes
PRIMARYHLAHADAC
Energy-Based Surgical Devices (Electrosurgery, RF, Ultrasonic, Laser)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Surgical Instruments, Endoscopy & OR Equipment
SECONDARYHLAHADAM
Single-Use Surgical Devices & Procedure Packs (Disposable instruments, drapes, kits)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Surgical Instruments, Endoscopy & OR Equipment
NAICS code2 codes
  • Surgical and Medical Instrument Manufacturing339112
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
SIC code2 codes
  • Surgical & Medical Instruments & Apparatus3841
  • Electromedical & Electrotherapeutic Apparatus3845
Product category
Surgical Instruments — Electrosurgical Burn Protection Devices
GTM motion4 records

Each record includes

Type, Description, Source

Revenue model4 records
1Capital Equipment Sales (AEM Monitors / Burn Protection Systems)
TypeHardware Sales
Description

One-time sale of AEM EndoShield® 2 Burn Protection System (catalog #EM200) and previously the EM3 AEM Monitor. Sold as reusable capital equipment to hospitals.

encision.com
2Disposable & Reposable Instrument Sales
TypeHardware Sales
Description

Recurring and repeat revenue from disposable AEM electrodes, AEM Burn Protection Cables (ES6107+), disposable e-Edge scissors, disposable sheath, and reposable enTouch 2x Scissors (2 uses per unit). Catalog products include ES0000-series and ES0100-series instruments.

encision.com
3Licensing, Supply & OEM Relationships
TypeLicensing Royalties
Description

Manufacturing, supply, and licensing arrangements with surgical robotics and medical device partners (Intuitive Surgical 2009; Auris Health 2021; Human Xtensions 2023; Vicarious Surgical 2023 PoC and 2024 MSA) — generating licensing/royalty or supply revenue tied to AEM technology.

encision.com
4Equity / Private Placement Capital Raises
TypeHardware Sales
Description

Non-operating capital raises via private placement of common stock (e.g., $500,000 placement completed August 19, 2025) used to fund new product development (ENT device) and sales.

pharmiweb.com
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels5 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure, Supply Chain
Pricing details3 tiers
1Quote-based, not publicly listed — hospitals schedule a Free Clinical Evaluation
ModelOther
Notes

No public list price. Sales are handled via direct sales contact (Ph: 800.998.0986 / 303-444-2600) and free clinical evaluation. Value proposition emphasizes cost reduction (free Shield Instruments, reposable 2x Scissors).

encision.com
2Unit pricing on consumables and instruments (sold by the box / case)
ModelUnit Pricing
Notes

Disposables sold in box quantities (e.g., 5mm Disposable Foot Activated Electrodes in Box of 10; AEM Burn Protection Cable ES6107+ in 25/box; Hand Switching Hand Piece in 25/box). AEM Reusable Suction Irrigation Electrodes and handles sold individually. No unit price disclosed.

encision.com
3Value-based pricing anchored on 100% Hold Harmless Indemnity Guarantee
ModelOther
Notes

Company offers complete legal indemnity to physicians and hospitals using AEM instrumentation against stray energy burns; pricing reflects a risk-shift / patient-safety value proposition rather than per-unit commodity pricing.

encision.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 7 records shown
1AEM® Shield™
Description

Encision's branded line of shielded AEM® laparoscopic surgical instruments designed to eliminate stray energy burns during minimally invasive surgery; awarded a Vizient Innovative Technology Contract.

encision.com
+6 more records
Core offering1 text field

Encision develops, manufactures, and sells proprietary AEM® (Active Electrode Monitoring) laparoscopic surgical instruments and burn protection systems designed to eliminate stray energy burns during monopolar electrosurgery. Its product line includes capital equipment (AEM EndoShield® 2 Burn Protection System), reusable, reposable, and disposable shielded laparoscopic instruments (electrodes, scissors, graspers, sheaths), and burn protection cables, sold primarily to US hospitals and surgical centers through direct sales, GPO contracts, and international distributors.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • Patient burned every 90 minutes in the USA during laparoscopic surgery (marketing-cited; 1–2 patient deaths per day) — AEM technology positioned to eliminate these.
+3 more records
Product and service5 records
1AEM EndoShield® 2 Burn Protection System
CategoryCapital Equipment — Electrosurgical Burn Protection Monitor
Description

Plug-and-play smart cord / monitor that serves as the hub of the AEM system, interfacing with AEM instruments and ESU generators to actively monitor insulation and prevent stray energy burns. Catalog #EM200. Sold as reusable capital equipment to hospitals.

2AEM® EM3 Burn Protection Monitor
CategoryCapital Equipment — Electrosurgical Burn Protection Monitor
Description

Plug-and-play AEM monitor with integrated hand control, compatible with popular electrosurgical units (ESUs) via adapters (Olympus, Conmed). The EM3 Product Family was discontinued as of February 2026.

3AEM® Shield™ Laparoscopic Instruments
CategoryLaparoscopic Surgical Instruments — Shielded Electrodes
Description

Shielded AEM® laparoscopic surgical instruments (electrodes, graspers, dissectors) that actively monitor the active electrode during minimally invasive surgery and shut down the electrosurgical generator if an insulation fault or dangerous capacitive coupling is detected. Includes AEM Reusable, Disposable, and Reposable instruments in the ES0000-series and ES0100-series catalog.

4AEM enTouch® Reposable 2x Scissors
CategoryLaparoscopic Surgical Instruments — Reposable Scissors
Description

Reposable (2-use) laparoscopic scissors with micro-serrated blades, color indicators showing when to replace, and a high-performance AEM enTouch® handle with tactile feedback. Designed to be sharp, responsive, and to reduce cost and waste.

5AEM e-Edge® Disposable Scissors
Scale indicator10 records

Each record includes

Type, Value, Description, Source

Partnership17 partners
Strategic tierHigh — Robotics Co-Development Relationship (Poc Feb 2023; Msa Aug 2024)TypeStrategic or Co-development PartnerAnnounced on2024-08-21
Description

Signed a Master Services Agreement on August 21, 2024, following a Proof-of-Concept Agreement signed February 14, 2023. Vicarious Surgical is a robotics company; the relationship appears aimed at integrating Encision's AEM technology into next-generation surgical robotics platforms.

Strategic tierCore — Supplier Agreement For Handheld Surgical RoboticsTypeOEM/ Whitelabel/ Licensing PartnerAnnounced on2023-02-28
Description

Supplier Agreement signed February 28, 2023, with Human Xtensions, an Israel-based developer of handheld surgical robotics. Encision supplies AEM technology/components for integration.

Strategic tierHigh — Supply Relationship With A Johnson & Johnson Surgical Robotics SubsidiaryTypeOEM/ Whitelabel/ Licensing PartnerAnnounced on2021-08-24
Description

Supply Agreement signed August 24, 2021. Auris Health (a J&J subsidiary focused on surgical robotics, including the Monarch platform) is supplied by Encision under this agreement. Form 8-K filings in 2020 also reference Auris.

Strategic tierFlagship — Second-Generation Contract (Ms1306) Covers 97% Of Us Academic Medical Centers And 60% Of Acute Care HospitalsTypeChannel Partner/ Reseller/ DistributorAnnounced on2019-04-02
Description

Encision's AEM® Shield™ Laparoscopic Instruments received a Vizient Innovative Technology Contract (initial April 2, 2019), later renewed as a Second-Generation Innovative Technology Contract (MS1306). Vizient is the nation's leading healthcare improvement company, and the contract is based on a member-led hospital expert council recommendation. There is no other technology on the market providing the same patient-safety, performance and value combination.

Strategic tierMinor — Exclusive Distribution Agreement (Older)TypeChannel Partner/ Reseller/ DistributorAnnounced on2013-04-16
Description

Exclusive Distribution Agreement for Laparoscopic Surgery Devices announced April 16, 2013, between Encision Inc. and Virtual Ports Ltd.

Strategic tierCore — Gpo Purchasing Agreement For Member HospitalsTypeChannel Partner/ Reseller/ DistributorAnnounced on2010-06-01
Description

Purchasing Agreement signed June 1, 2010, between Encision and HealthTrust Purchasing Group, a healthcare GPO serving member hospitals.

Strategic tierHigh — Long-Running Non-Exclusive Manufacturing, Supply And Licensing Agreement With The Market-Leading Surgical Robotics CompanyTypeOEM/ Whitelabel/ Licensing PartnerAnnounced on2009-04-08
Description

Non-Exclusive Manufacturing, Supply and Licensing Agreement signed April 8, 2009. Encision's Q3/Q4 FY2026 earnings commentary noted that Intuitive Surgical's robots are replacing procedures that historically used Encision's AEM instrumentation, suggesting the relationship has shifted to one where Intuitive increasingly captures the procedure volume.

Strategic tierMinor — Sales Representation AgreementTypeChannel Partner/ Reseller/ DistributorAnnounced on2009-03-25
Description

Sales Representation Agreement signed March 25, 2009, between Encision and Caldera Medical.

Strategic tierCore — Extended Gpo Supplier Agreement For Member HospitalsTypeChannel Partner/ Reseller/ DistributorAnnounced on2004-06-17
Description

Supplier Agreement extended June 17, 2004. Premier is a major healthcare GPO; the relationship covers Encision's AEM Surgical Instruments for Premier member hospitals.

10Gytech PTY LTD
Strategic tierCore — Exclusive Australia Distribution ChannelTypeChannel Partner/ Reseller/ Distributor
Description

Australian distribution partner. Janet Padgham serves as Director of Sales (jpadgham@gytech.com.au, www.gytech.com.au). Listed as Encision's Australia contact on the official Sales page.

encision.com
Strategic tierCore — New Zealand Distribution ChannelTypeChannel Partner/ Reseller/ Distributor
Description

New Zealand distribution partner. Contact: info@obex.co.nz, Ph 09-630-3456, Fax 09-630-9009. Listed as Encision's New Zealand contact on the official Sales page.

Strategic tierCore — Co-Developer Of Accredited Nursing Continuing EducationTypeGTM or Marketing Partner
Description

Pfiedler Education developed the 'Safer Surgery Together' virtual CE course on behalf of / with Encision. The course is free for local AORN chapters and coworkers, delivered in person or via Zoom for 2 nursing contact hours. Pfiedler Enterprises is a California Board of Nursing approved provider (Provider Number CEP 13019).

Strategic tierMinor — Administrative Service ProviderTypeOthers
Description

Computershare serves as Encision's Transfer Agent. Mailing address: P.O. Box 43006, Providence, RI 02940-3006. Courier delivery: 150 Royall St., Suite 101, Canton, MA 02021.

14AORN (Association of periOperative Registered Nurses)
Strategic tierCore — Clinical Practice Guideline EndorsementTypeGTM or Marketing Partner
Description

Encision's AEM technology has been cited in AORN Recommended Practices and the AORN Electrosurgical Safety Guideline, which recommends use of an Active Electrode Monitoring (AEM®) and Shielding Device during minimally invasive surgery. Encision offers free continuing education to AORN chapter members.

encision.com
Strategic tierCore — Clinical Society EndorsementTypeGTM or Marketing Partner
Description

AEM technology was presented at SAGES (April 7, 2004) and is cited as a recommended practice of SAGES for electrosurgical safety (per EM3 Monitor product page). Encision participated in the 2010 Minimally Invasive Gynecology Congress.

Strategic tierCore — Clinical Society EndorsementTypeGTM or Marketing Partner
Description

Encision's AEM technology has been presented at AAGL (November 17, 2005; 2010) and is cited as a recommended practice of AAGL for electrosurgical safety (per EM3 Monitor product page).

Strategic tierHistorical — Encision Deregistered In 2026TypeOthers
Description

Encision filed a Form 15 with the SEC in January 2026 (Form 15-12G filed 01/29/2026; Form 15-12G/A filed 06/10/2026) to voluntarily deregister its common stock under Section 12(g) of the Securities Exchange Act of 1934. SEC EDGAR CIK 0000930775. Trading halted and OTC Markets application initiated.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Specialist in electrosurgical generators, smoke evacuation and laparoscopic instruments; also referenced as an Encision EM3 compatibility partner. Closely comparable in product scope (electrosurgery + laparoscopy) and target customer (hospital ORs).

TypeDirect peer
Description

Privately-held developer and manufacturer of laparoscopic surgical instruments, trocars, and energy devices focused on patient safety and cost. Closely aligned with Encision in target market (US hospitals) and emphasis on clinical-economics-driven value propositions.

TypeBroad incumbent
Description

Major surgical instruments manufacturer (Aesculap division) supplying laparoscopic and electrosurgical instruments globally. Comparable in hospital-channel sales motion and reusable/reposable instrument mix.

TypeDirect peer
Description

German specialist in electrosurgical generators and instruments, including vessel-sealing and monopolar/bipolar systems for minimally invasive surgery. Closely comparable technology footprint to Encision's AEM line and active in the same electrosurgery-safety narrative.

TypeEmerging player
Description

Early-stage surgical robotics company that signed a Master Services Agreement with Encision in August 2024 (after a 2023 PoC). Relevant both as a direct OEM/licensing partner comparable to the relationship dynamic Encision has with Intuitive and as a peer in adjacent surgical robotics commercialization.

TypeBroad incumbent
Description

Large diversified surgical device maker with a significant surgical instruments and energy platform. Comparable buyer/customer profile (hospitals, IDNs, GPOs) and overlaps with Encision in monopolar/bipolar laparoscopic instrumentation.

TypeBroad incumbent
Description

Diversified medtech giant with a broad surgical instruments and electrosurgery portfolio (including the Valleylab energy franchise). Sells laparoscopic instruments and electrosurgical generators that compete for the same OR budget as Encision's AEM products.

TypeBroad incumbent
Description

Market-leading robotic surgical platform (da Vinci) and a long-time Encision OEM partner (2009 licensing agreement). Direct overlap in laparoscopic electrosurgical delivery and the principal disruptor cited by Encision management as causing procedure-volume displacement.

9Johnson & Johnson (Ethicon / Auris Health)
TypeBroad incumbent
Description

Ethicon supplies surgical instruments and energy devices; Auris Health (J&J subsidiary, Monarch platform) signed an Encision supply agreement in 2021. Comparable as both an electrosurgical competitor and an OEM/licensing counterparty.

TypeBroad incumbent
Description

Major manufacturer of laparoscopic surgical instruments and electrosurgical generators referenced as an EM3 compatibility partner. Competes with Encision in reusable laparoscopic instrument market segments and bundled OR solutions.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks7 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers4 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles6 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds4 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Encision

Surgical Instruments — Electrosurgical Burn Protection Devicesencision.com

Encision Inc. is a Boulder, Colorado medical device company that develops AEM® Active Electrode Monitoring laparoscopic surgical instruments designed to eliminate stray energy burns, selling capital equipment and disposable/reposable instruments to US hospitals via GPO contracts and licensing to surgical robotics partners.

What Encision does

Encision Inc. is a Boulder, Colorado-based medical device company founded in 1991 that develops and manufactures Active Electrode Monitoring (AEM®) technology and laparoscopic surgical instruments designed to eliminate stray energy burns to patients during minimally invasive surgery. The company's core technology — AEM® — electrically shields the laparoscopic instrument shaft and continuously monitors insulation integrity during use, automatically shutting down the electrosurgical generator when an insulation fault or capacitive coupling is detected. Its product portfolio includes the AEM EndoShield® 2 Burn Protection System (capital equipment, FDA 510(k) cleared June 2014), AEM enTouch® Reposable 2x Scissors, AEM e-Edge® disposable scissors, AEM Shield™ laparoscopic instruments, the EM3 Burn Protection Monitor (discontinued February 2026), and PowerGrip® bipolar instruments. The company also offers a distinctive 100% Hold Harmless Indemnity Guarantee to physicians and hospitals using AEM instrumentation.

Encision monetizes through three primary revenue streams: (1) one-time capital equipment sales of AEM monitors/burn protection systems to hospitals; (2) recurring disposable and reposable instrument sales (consumables such as electrodes, cables, scissors and sheaths); and (3) licensing/supply arrangements with surgical robotics companies including Intuitive Surgical (2009), Auris Health / J&J (2021), Human Xtensions (2023), and Vicarious Surgical (2023 PoC / 2024 MSA). Pricing is quote-based and not publicly disclosed; sales are handled via direct enterprise outreach out of Boulder, CO headquarters to US hospitals, supplemented by international channel partners Gytech PTY LTD (Australia) and Obex (New Zealand), and GPO contracts with Vizient (Second-Generation Innovative Technology Contract MS1306, covering ~97% of US academic medical centers and ~60% of acute care hospitals), Premier and HealthTrust. Encision was previously listed on AMEX (2004), moved to OTC Bulletin Board (2008), traded as ECIA on OTC US, and voluntarily deregistered from the SEC via Form 15 in January 2026 to pursue quotation on OTC Markets.

Recent financial performance shows a declining revenue trajectory attributed by management to Intuitive Surgical's robots displacing procedures that historically used AEM instrumentation: Q4 FY2026 net sales were $1,241K, down 12% sequentially from $1,413K in Q3 FY2026 and from $1,528K in Q2 FY2026. The company narrowed its Q4 FY2026 net loss to $96K (from $314K in Q3) and improved gross margin by 9.3 percentage points to 47.7% following a completed restructuring that reduced operating expenses by 22.6% and produced operating profitability in March. A $500,000 private placement completed August 19, 2025 is funding development of a new ENT (Ear, Nose and Throat) device planned for early 2026. CEO Gregory Trudel resigned in December 2025 after 12 years amid disagreement over company direction, and Robert Fries was appointed interim President and CEO.

Encision firmographics

Firmographics
Name
Encision
Legal name
Encision Inc.
Website
https://encision.com
Company type
Public
Founded year
1991
Operating status
Operating
Headcount range
11–50 employees
Short description
Encision Inc. is a Boulder, Colorado medical device company that develops AEM® Active Electrode Monitoring laparoscopic surgical instruments designed to eliminate stray energy burns, selling capital equipment and disposable/reposable instruments to US hospitals via GPO contracts and licensing to surgical robotics partners.
Ownership category
akta.pro rank

Encision industry classification

Industry
Product category
Surgical Instruments — Electrosurgical Burn Protection Devices
NAICS
Surgical and Medical Instrument Manufacturing (339112), Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
SIC
Surgical & Medical Instruments & Apparatus (3841), Electromedical & Electrotherapeutic Apparatus (3845)
akta.pro industry
PRIMARYHLAHADAC
Energy-Based Surgical Devices (Electrosurgery, RF, Ultrasonic, Laser)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Surgical Instruments, Endoscopy & OR Equipment
SECONDARYHLAHADAM
Single-Use Surgical Devices & Procedure Packs (Disposable instruments, drapes, kits)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Surgical Instruments, Endoscopy & OR Equipment

Keywords

  • Electrosurgical safety devices
  • Laparoscopic surgical instruments
  • Active electrode monitoring
  • Burn protection systems
  • Minimally invasive surgery

Where Encision is headquartered

Location

Headquarters

HQ city
Boulder
HQ country
United States
HQ region
North America

Offices3 records

Markets served

Encision business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure, Supply Chain

Revenue model

  1. Capital Equipment Sales (AEM Monitors / Burn Protection Systems): One-time sale of AEM EndoShield® 2 Burn Protection System (catalog #EM200) and previously the EM3 AEM Monitor. Sold as reusable capital equipment to hospitals.
  2. Disposable & Reposable Instrument Sales: Recurring and repeat revenue from disposable AEM electrodes, AEM Burn Protection Cables (ES6107+), disposable e-Edge scissors, disposable sheath, and reposable enTouch 2x Scissors (2 uses per unit). Catalog products include ES0000-series and ES0100-series instruments.
  3. Licensing, Supply & OEM Relationships: Manufacturing, supply, and licensing arrangements with surgical robotics and medical device partners (Intuitive Surgical 2009; Auris Health 2021; Human Xtensions 2023; Vicarious Surgical 2023 PoC and 2024 MSA) — generating licensing/royalty or supply revenue tied to AEM technology.
  4. Equity / Private Placement Capital Raises: Non-operating capital raises via private placement of common stock (e.g., $500,000 placement completed August 19, 2025) used to fund new product development (ENT device) and sales.

Pricing tiers

ModelBillingPrice
Other—Quote-based, not publicly listed — hospitals schedule a Free Clinical Evaluation
Unit Pricing—Unit pricing on consumables and instruments (sold by the box / case)
Other—Value-based pricing anchored on 100% Hold Harmless Indemnity Guarantee

Go-to-market motion4 records

Distribution channels5 records

Marketing channels7 records

Encision product offering

Product offering

Core offering

Encision develops, manufactures, and sells proprietary AEM® (Active Electrode Monitoring) laparoscopic surgical instruments and burn protection systems designed to eliminate stray energy burns during monopolar electrosurgery. Its product line includes capital equipment (AEM EndoShield® 2 Burn Protection System), reusable, reposable, and disposable shielded laparoscopic instruments (electrodes, scissors, graspers, sheaths), and burn protection cables, sold primarily to US hospitals and surgical centers through direct sales, GPO contracts, and international distributors.

Differentiator

Problem solved

Functional benefit

Brands

  • AEM® Shield™: Encision's branded line of shielded AEM® laparoscopic surgical instruments designed to eliminate stray energy burns during minimally invasive surgery; awarded a Vizient Innovative Technology Contract.
  • AEM EndoShield® / AEM EndoShield® 2 Burn Protection System
  • AEM enTouch®
  • AEM e-Edge®
  • AEM® EM3 Burn Protection Monitor
  • PowerGrip®
  • e·Access™

Products and services

  • AEM EndoShield® 2 Burn Protection System Plug-and-play smart cord / monitor that serves as the hub of the AEM system, interfacing with AEM instruments and ESU generators to actively monitor insulation and prevent stray energy burns. Catalog #EM200. Sold as reusable capital equipment to hospitals.
  • AEM® EM3 Burn Protection Monitor Plug-and-play AEM monitor with integrated hand control, compatible with popular electrosurgical units (ESUs) via adapters (Olympus, Conmed). The EM3 Product Family was discontinued as of February 2026.
  • AEM® Shield™ Laparoscopic Instruments Shielded AEM® laparoscopic surgical instruments (electrodes, graspers, dissectors) that actively monitor the active electrode during minimally invasive surgery and shut down the electrosurgical generator if an insulation fault or dangerous capacitive coupling is detected. Includes AEM Reusable, Disposable, and Reposable instruments in the ES0000-series and ES0100-series catalog.
  • AEM enTouch® Reposable 2x Scissors Reposable (2-use) laparoscopic scissors with micro-serrated blades, color indicators showing when to replace, and a high-performance AEM enTouch® handle with tactile feedback. Designed to be sharp, responsive, and to reduce cost and waste.
  • AEM e-Edge® Disposable Scissors

Quantifiable outcome

  • Patient burned every 90 minutes in the USA during laparoscopic surgery (marketing-cited; 1–2 patient deaths per day) — AEM technology positioned to eliminate these.
  • +3 more outcomes

Companies that use Encision

Customer profile

Named customers4 records

Segments4 records

Ideal customer profiles3 records

Encision technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature5 records

Encision partnerships and signals

Strategic signal

Partnerships

17 partnerships are on record, tiered high — robotics co-development relationship (poc feb 2023; msa aug 2024), core — supplier agreement for handheld surgical robotics, high — supply relationship with a johnson & johnson surgical robotics subsidiary, flagship — second-generation contract (ms1306) covers 97% of us academic medical centers and 60% of acute care hospitals, minor — exclusive distribution agreement (older), core — gpo purchasing agreement for member hospitals, high — long-running non-exclusive manufacturing, supply and licensing agreement with the market-leading surgical robotics company, minor — sales representation agreement, core — extended gpo supplier agreement for member hospitals, core — exclusive australia distribution channel, core — new zealand distribution channel, core — co-developer of accredited nursing continuing education, minor — administrative service provider, core — clinical practice guideline endorsement, core — clinical society endorsement and historical — encision deregistered in 2026.

  • Vicarious Surgical Inc.high — robotics co-development relationship (poc feb 2023; msa aug 2024)Strategic or Co-development Partner · 21 August 2024Signed a Master Services Agreement on August 21, 2024, following a Proof-of-Concept Agreement signed February 14, 2023. Vicarious Surgical is a robotics company; the relationship appears aimed at integrating Encision's AEM technology into next-generation surgical robotics platforms.
  • Human Xtensionscore — supplier agreement for handheld surgical roboticsOEM/ Whitelabel/ Licensing Partner · 28 February 2023Supplier Agreement signed February 28, 2023, with Human Xtensions, an Israel-based developer of handheld surgical robotics. Encision supplies AEM technology/components for integration.
  • Auris Health, Inc.high — supply relationship with a johnson & johnson surgical robotics subsidiaryOEM/ Whitelabel/ Licensing Partner · 24 August 2021Supply Agreement signed August 24, 2021. Auris Health (a J&J subsidiary focused on surgical robotics, including the Monarch platform) is supplied by Encision under this agreement. Form 8-K filings in 2020 also reference Auris.
  • Vizientflagship — second-generation contract (ms1306) covers 97% of us academic medical centers and 60% of acute care hospitalsChannel Partner/ Reseller/ Distributor · 2 April 2019Encision's AEM® Shield™ Laparoscopic Instruments received a Vizient Innovative Technology Contract (initial April 2, 2019), later renewed as a Second-Generation Innovative Technology Contract (MS1306). Vizient is the nation's leading healthcare improvement company, and the contract is based on a member-led hospital expert council recommendation. There is no other technology on the market providing the same patient-safety, performance and value combination.
  • Virtual Ports Ltd.minor — exclusive distribution agreement (older)Channel Partner/ Reseller/ Distributor · 16 April 2013Exclusive Distribution Agreement for Laparoscopic Surgery Devices announced April 16, 2013, between Encision Inc. and Virtual Ports Ltd.
  • HealthTrust Purchasing Groupcore — gpo purchasing agreement for member hospitalsChannel Partner/ Reseller/ Distributor · 1 June 2010Purchasing Agreement signed June 1, 2010, between Encision and HealthTrust Purchasing Group, a healthcare GPO serving member hospitals.
  • Intuitive Surgicalhigh — long-running non-exclusive manufacturing, supply and licensing agreement with the market-leading surgical robotics companyOEM/ Whitelabel/ Licensing Partner · 8 April 2009Non-Exclusive Manufacturing, Supply and Licensing Agreement signed April 8, 2009. Encision's Q3/Q4 FY2026 earnings commentary noted that Intuitive Surgical's robots are replacing procedures that historically used Encision's AEM instrumentation, suggesting the relationship has shifted to one where Intuitive increasingly captures the procedure volume.
  • Caldera Medicalminor — sales representation agreementChannel Partner/ Reseller/ Distributor · 25 March 2009Sales Representation Agreement signed March 25, 2009, between Encision and Caldera Medical.
  • Premiercore — extended gpo supplier agreement for member hospitalsChannel Partner/ Reseller/ Distributor · 17 June 2004Supplier Agreement extended June 17, 2004. Premier is a major healthcare GPO; the relationship covers Encision's AEM Surgical Instruments for Premier member hospitals.
  • Gytech PTY LTDcore — exclusive australia distribution channelChannel Partner/ Reseller/ DistributorAustralian distribution partner. Janet Padgham serves as Director of Sales (jpadgham@gytech.com.au, www.gytech.com.au). Listed as Encision's Australia contact on the official Sales page.
  • Obexcore — new zealand distribution channelChannel Partner/ Reseller/ DistributorNew Zealand distribution partner. Contact: info@obex.co.nz, Ph 09-630-3456, Fax 09-630-9009. Listed as Encision's New Zealand contact on the official Sales page.
  • Pfiedler Education (Pfiedler Enterprises)core — co-developer of accredited nursing continuing educationGTM or Marketing PartnerPfiedler Education developed the 'Safer Surgery Together' virtual CE course on behalf of / with Encision. The course is free for local AORN chapters and coworkers, delivered in person or via Zoom for 2 nursing contact hours. Pfiedler Enterprises is a California Board of Nursing approved provider (Provider Number CEP 13019).
  • Computershareminor — administrative service providerOthersComputershare serves as Encision's Transfer Agent. Mailing address: P.O. Box 43006, Providence, RI 02940-3006. Courier delivery: 150 Royall St., Suite 101, Canton, MA 02021.
  • AORN (Association of periOperative Registered Nurses)core — clinical practice guideline endorsementGTM or Marketing PartnerEncision's AEM technology has been cited in AORN Recommended Practices and the AORN Electrosurgical Safety Guideline, which recommends use of an Active Electrode Monitoring (AEM®) and Shielding Device during minimally invasive surgery. Encision offers free continuing education to AORN chapter members.
  • SAGES (Society of American Gastrointestinal and Endoscopic Surgeons)core — clinical society endorsementGTM or Marketing PartnerAEM technology was presented at SAGES (April 7, 2004) and is cited as a recommended practice of SAGES for electrosurgical safety (per EM3 Monitor product page). Encision participated in the 2010 Minimally Invasive Gynecology Congress.
  • AAGL (American Association of Gynecologic Laparoscopists)core — clinical society endorsementGTM or Marketing PartnerEncision's AEM technology has been presented at AAGL (November 17, 2005; 2010) and is cited as a recommended practice of AAGL for electrosurgical safety (per EM3 Monitor product page).
  • SEC (Securities and Exchange Commission)historical — encision deregistered in 2026OthersEncision filed a Form 15 with the SEC in January 2026 (Form 15-12G filed 01/29/2026; Form 15-12G/A filed 06/10/2026) to voluntarily deregister its common stock under Section 12(g) of the Securities Exchange Act of 1934. SEC EDGAR CIK 0000930775. Trading halted and OTC Markets application initiated.

Scale indicators10 records

Recent moves7 records

Expansion highlights5 records

Encision competitors and assessment

Company assessment

Direct peers

  • CONMED Corporation: Specialist in electrosurgical generators, smoke evacuation and laparoscopic instruments; also referenced as an Encision EM3 compatibility partner. Closely comparable in product scope (electrosurgery + laparoscopy) and target customer (hospital ORs).
  • Applied Medical Resources: Privately-held developer and manufacturer of laparoscopic surgical instruments, trocars, and energy devices focused on patient safety and cost. Closely aligned with Encision in target market (US hospitals) and emphasis on clinical-economics-driven value propositions.
  • Erbe Elektromedizin: German specialist in electrosurgical generators and instruments, including vessel-sealing and monopolar/bipolar systems for minimally invasive surgery. Closely comparable technology footprint to Encision's AEM line and active in the same electrosurgery-safety narrative.

Broad incumbents

  • B. Braun (Aesculap): Major surgical instruments manufacturer (Aesculap division) supplying laparoscopic and electrosurgical instruments globally. Comparable in hospital-channel sales motion and reusable/reposable instrument mix.
  • Stryker Corporation: Large diversified surgical device maker with a significant surgical instruments and energy platform. Comparable buyer/customer profile (hospitals, IDNs, GPOs) and overlaps with Encision in monopolar/bipolar laparoscopic instrumentation.
  • Medtronic: Diversified medtech giant with a broad surgical instruments and electrosurgery portfolio (including the Valleylab energy franchise). Sells laparoscopic instruments and electrosurgical generators that compete for the same OR budget as Encision's AEM products.
  • Intuitive Surgical: Market-leading robotic surgical platform (da Vinci) and a long-time Encision OEM partner (2009 licensing agreement). Direct overlap in laparoscopic electrosurgical delivery and the principal disruptor cited by Encision management as causing procedure-volume displacement.
  • Johnson & Johnson (Ethicon / Auris Health): Ethicon supplies surgical instruments and energy devices; Auris Health (J&J subsidiary, Monarch platform) signed an Encision supply agreement in 2021. Comparable as both an electrosurgical competitor and an OEM/licensing counterparty.
  • Olympus Corporation: Major manufacturer of laparoscopic surgical instruments and electrosurgical generators referenced as an EM3 compatibility partner. Competes with Encision in reusable laparoscopic instrument market segments and bundled OR solutions.

Emerging players

  • Vicarious Surgical: Early-stage surgical robotics company that signed a Master Services Agreement with Encision in August 2024 (after a 2023 PoC). Relevant both as a direct OEM/licensing partner comparable to the relationship dynamic Encision has with Intuitive and as a peer in adjacent surgical robotics commercialization.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat4 records

Key risks7 records

Key highlights7 records

Customer concentration

Encision social profiles

Digital presence

Encision financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Encision leadership team

Management profile

Number of profiles

Profiles6 records

Encision funding detail

Funding detail

Funding overview

Funding rounds4 records

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Encision M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Encision

What does Encision do?

Encision develops, manufactures, and sells proprietary AEM® (Active Electrode Monitoring) laparoscopic surgical instruments and burn protection systems designed to eliminate stray energy burns during monopolar electrosurgery. Its product line includes capital equipment (AEM EndoShield® 2 Burn Protection System), reusable, reposable, and disposable shielded laparoscopic instruments (electrodes, scissors, graspers, sheaths), and burn protection cables, sold primarily to US hospitals and surgical centers through direct sales, GPO contracts, and international distributors.

Is Encision a public or private company?

Encision is a public company. It is classified as public and is currently operating.

When was Encision founded?

Encision was founded in 1991. It employs 11 to 50 people.

Where is Encision based?

Encision is headquartered in Boulder, United States, in the North America region.

How does Encision make money?

Four revenue lines are on record. Capital Equipment Sales (AEM Monitors / Burn Protection Systems) is the primary driver. The others are disposable & Reposable Instrument Sales, licensing, Supply & OEM Relationships and equity / Private Placement Capital Raises.

Who are Encision's main competitors?

Direct peers on record are CONMED Corporation, Applied Medical Resources and Erbe Elektromedizin. Broad incumbents are B. Braun (Aesculap), Stryker Corporation, Medtronic, Intuitive Surgical, Johnson & Johnson (Ethicon / Auris Health) and Olympus Corporation. Vicarious Surgical is listed as an emerging player.

Does Encision have an API?

No public API is recorded for Encision.

What industry is Encision in?

Encision's product category is Surgical Instruments — Electrosurgical Burn Protection Devices. Its primary akta.pro industry code is HLAHADAC, Energy-Based Surgical Devices (Electrosurgery, RF, Ultrasonic, Laser), with a secondary code of HLAHADAM, Single-Use Surgical Devices & Procedure Packs (Disposable instruments, drapes, kits). Its NAICS code is 339112 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
AInvestEncision Went Dark, Then Sold Its Own Directors 2 Million Shares for $80,000Encision completed an $80,000 private placement by selling 2 million shares at $0.04 each to its directors. The company's revenue fell to $5.78 million in fiscal 2026, and it has about 18.9 million shares outstanding. Management expects the next quarter to be profitable.YahooEncision Completes $80,000 Private PlacementEncision Inc. completed an $80,000 private placement of common stock on September 8, 2026, issuing 2 million shares at $0.04 per share. The funds will be used for general working capital, and the company now has 18,879,645 total common shares outstanding.FinancialContent Business PageEncision Completes $80,000 Private PlacementEncision Inc. completed an $80,000 private placement of common stock on September 8, 2026, issuing 2 million shares at $0.04 per share to a group of private investors. The funds will be used for general working capital, and the company now has 18,879,645 total common shares outstanding.Stock TitanEncision Completes $80K Private PlacementEncision Inc. completed an $80,000 private placement of common stock on September 8, 2026, with director investors. The company issued 2 million shares at $0.04 per share, bringing total outstanding shares to 18,879,645. The funds will be used for general working capital.citybizEncision Raises $80,000 From Directors to Support Working CapitalEncision Inc. raised $80,000 from its board of directors in a private placement, issuing 2 million shares at $0.04 each. The funds will support general working capital, and the company's total shares outstanding rose to about 18.9 million.BioSpaceEncision Completes $80,000 Private PlacementEncision Inc. completed an $80,000 private placement of common stock on September 8, 2026, issuing 2 million shares at $0.04 per share to a group of private investors. The funds will be used for general working capital, and the company now has 18,879,645 total common shares outstanding.MorningstarEncision Completes $80,000 Private PlacementEncision Inc. completed an $80,000 private placement of common stock on September 8, 2026, issuing 2 million shares at $0.04 per share to a group of directors. The funds will be used for general working capital, and the company now has 18,879,645 total common shares outstanding.BioSpaceEncision Inc. Announces Start of Stock TradingEncision Inc. announced that trading in its common stock has started on the OTC Markets under the symbol ECIA. The medical device company, based in Boulder, Colorado, markets surgical instrumentation with patented Active Electrode Monitoring technology to prevent stray energy burns during minimally invasive procedures.FinancialContent Business PageEncision Inc. Announces Start of Stock TradingEncision Inc., a medical device company specializing in Active Electrode Monitoring (AEM®) technology for minimally invasive surgery, announced that trading in its common stock has commenced on the OTC Markets under the symbol ECIA. The company, based in Boulder, Colorado, designs and markets surgical instrumentation intended to prevent dangerous stray energy burns during procedures. This announcement marks the company's debut or return to public trading on the OTC Pink market.Stock TitanEncision ECIA Stock Trading Starts on OTC MarketsEncision Inc., a Boulder, Colorado-based medical device company specializing in Active Electrode Monitoring (AEM®) technology for minimally invasive surgery, announced that trading in its common stock has commenced on the OTC Markets under the symbol ECIA. The company designs and markets surgical instrumentation intended to prevent dangerous stray energy burns during procedures. This appears to be a routine market listing announcement rather than a significant corporate development.